Category: Interviews - Psychedelic Alpha

Read more about the article The VA, Psychedelics, and the Future of Mental Health: A Conversation with Shereef Elnahal, Former VA Under Secretary for Health

The VA, Psychedelics, and the Future of Mental Health: A Conversation with Shereef Elnahal, Former VA Under Secretary for Health

Post published:April 14, 2025
Post category:Interviews

Read more about the article Behind the Bill: Inside a Bipartisan Effort to Bring Psychedelic Therapy to Veterans

Behind the Bill: Inside a Bipartisan Effort to Bring Psychedelic Therapy to Veterans

Post published:April 4, 2025
Post category:Interviews

Read more about the article Inside the World’s Most Active Psychedelic Therapy Site: A Conversation with Sunstone Therapies

Inside the World’s Most Active Psychedelic Therapy Site: A Conversation with Sunstone Therapies

Post published:March 12, 2025
Post category:Interviews Pα+

Read more about the article Forging a Path to Access: Congressmen Correa and Bergman on the Future of Psychedelics in the U.S.

Forging a Path to Access: Congressmen Correa and Bergman on the Future of Psychedelics in the U.S.

Post published:March 4, 2025
Post category:Interviews

Read more about the article MDMA for Active-Duty Troops: Aaron Wolfgang on DoD’s Unprecedented Study

MDMA for Active-Duty Troops: Aaron Wolfgang on DoD’s Unprecedented Study

Post published:February 19, 2025
Post category:Interviews Pα+

Read more about the article Magic Mushrooms Meet Corporate Conspiracy: Steve Hely on Adult Swim’s Common Side Effects

Magic Mushrooms Meet Corporate Conspiracy: Steve Hely on Adult Swim’s Common Side Effects

Post published:February 17, 2025
Post category:Interviews

Read more about the article mpathic Co-Founder Danielle Schlosser on AI Oversight of Psychedelics Trials

mpathic Co-Founder Danielle Schlosser on AI Oversight of Psychedelics Trials

Post published:January 17, 2025
Post category:Interviews Pα+

Read more about the article Bullish on Chaos: Matt Zorn on How Psychedelics Could Benefit from Trump’s Second Term

Bullish on Chaos: Matt Zorn on How Psychedelics Could Benefit from Trump’s Second Term

Post published:December 13, 2024
Post category:Interviews

Read more about the article Inside the FDA’s Psychedelics Journey: Javier Muniz, MD on Breakthroughs, Challenges, and the Future of the Field

Inside the FDA’s Psychedelics Journey: Javier Muniz, MD on Breakthroughs, Challenges, and the Future of the Field

Post published:December 5, 2024
Post category:Interviews Pα+

Read more about the article Exclusive: David Hough on Lykos’ Path to Resubmission

Exclusive: David Hough on Lykos’ Path to Resubmission

Post published:September 4, 2024
Post category:Interviews Pα+

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.